$12.56
-0.24-1.88%
At close: -
$12.56
0.000.00%
After Hours: 4:00 PM EDT
Inhibrx Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Inhibrx Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-2.84 | $-3.38 | 16.0 % |
Q2 | 2024-08-13 | $125.48 | $-1.47 | 8636.0 % |
Q1 | 2024-05-09 | $-1.44 | $-1.51 | 4.64 % |
Q4 | 2024-02-28 | $-1.73 | $-1.04 | -66.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2024-02-28 | $1.63M | $50.00K | 3168.0 % |
Q1 | 2023-05-08 | $17.00K | $150.00K | -88.7 % |
Q4 | 2023-03-06 | $274.00K | $790.00K | -65.3 % |
Q3 | 2022-11-07 | $278.00K | $630.00K | -55.9 % |
Inhibrx Biosciences (INBX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-2.84, which beat the estimate of $-3.38.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.